Latest Lead News

Great Divide Mining has raised $2.5 million through a share placement to fund development at its Challenger Gold Mine and progress other key projects.

360 Capital Mortgage REIT reported a robust half-year performance with a 40.5% increase in gross assets and a targeted 10.4% distribution yield for FY26, underpinned by disciplined lending and solid capital raising.

Mammoth Minerals has launched a new drilling phase at its Excelsior Gold-Silver Project in Nevada, revealing promising Carlin-style gold mineralisation that could significantly expand the project’s scale.

Elders Limited has announced René Dedoncker as its next CEO, set to begin in October 2026, with current CEO Mark Allison staying on through a transition period. Dedoncker brings two decades of agribusiness leadership experience from Fonterra and Mars Corporation.

SKS Technologies Group has upgraded its FY26 earnings forecast following $60 million in new contract awards, including major projects for NEXTDC and Ernst & Young. The company anticipates stronger revenue and profit margins driven by robust demand in data centre infrastructure.

FlexiRoam Limited reveals a strong financial turnaround with AI-powered innovations driving profitability and margin expansion in the first half of FY26. The company’s strategic partnerships and zero-integration platform position it well in the fast-growing eSIM market.

Mandrake Resources has received a US$1 million grant from the US Department of Energy to advance lithium exploration in Utah’s Paradox Basin, validating its Utah Lithium Project and strengthening partnerships with leading US research institutions.

Elevate Uranium has announced a significant upgrade to its Marenica Uranium Project in Namibia, doubling the resource grade and increasing contained uranium. This milestone enhances the project's development prospects and underpins the company's growth strategy.

Corazon Mining has identified a continuous 4-kilometre gold anomaly at its Two Pools Gold Project in Western Australia, revealing significant high-grade shallow intercepts and setting the stage for a maiden drilling campaign in early 2026.

Codeifai Limited has raised $1.1 million through a share placement that coincided with a sharp increase in its share price, confirming full compliance with ASX disclosure rules following a detailed inquiry.

Neuren Pharmaceuticals has received detailed feedback from the US FDA on its clinical development plans for NNZ-2591 targeting hypoxic ischemic encephalopathy and Pitt Hopkins syndrome, paving a clearer path forward despite some delays.

Orbminco Limited reports promising interim infill drilling results at its Majestic North Gold Project, confirming high-grade shallow gold zones and potential southern extensions. The company also secures $5 million in a two-tranche placement to accelerate resource delineation and development.